April 11, 2025 Marketing Team Press Releases Einstein Magazine – Harnessing an Ancient Remedy (Winter-Spring 2023) Read More April 11, 2025 Marketing Team Press Releases Artificial Cells, Nanomedicine, and Biotechnology – Novel Transdermal Curcumin Therapeutic Preserves Endothelial Barrier Function in a High Dose LPS Rat Model (2022) Read More March 31, 2025 Marketing Team Press Releases Anti-Cancer Linker Chemistry Read More March 31, 2025 Marketing Team Press Releases VAS-101 Enhances Red Blood Cell Preservation Read More March 31, 2025 Marketing Team Press Releases Promising Data for Transdermal Curcumin in Sickle Cell Disease Read More March 31, 2025 Marketing Team Press Releases Vascarta Presents Breakthrough Sickle Cell Treatment at ASH Conference Read More March 31, 2025 Marketing Team Press Releases Patented transdermal drug candidate from Vascarta may offer a convenient & cost-effective way to treat sickle cell disease Read More January 13, 2025 Marketing Team Scientific Papers Published poster: “Mechanism-based Targeting of Sickle Cell Pathobiology and Pain with Novel Transdermal Curcumin” Read More January 13, 2025 Marketing Team Scientific Papers FDA CBER & Vascarta Research Plan – Mechanistic insights into blood storage lesions and the development of antioxidant countermeasures Read More January 13, 2025 Marketing Team Scientific Papers Novel Transdermal Curcumin Therapeutic Preserves Endothelial Barrier Function in a Rat Model of Sepsis. Read More Previous page 1 2 3 4 Next page
